NCT04747067View on ClinicalTrials.gov

To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients.

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

May 1, 2021

Study Completion Date

September 1, 2021

Conditions
End Stage Renal DiseaseHemodiafiltrationHemodialysis
Interventions
DEVICE

BIOPURE 260HF dialyzer

Dialyzer with effective surface area 2.6 m2, High-flux polyethersulfone hollow fiber with steam sterilization, myoglobin sieving coefficient (SC) 0.7, membrane cutoff 40,000 Daltons (Allmed Medical Gmbh)

Trial Locations (1)

0000

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04747067 - To Assess the Effect of HDF Versus High Flux Dialysis on Free Light Chains and Cumulative Albumin Loss, in End Stage Renal Disease Patients. | Biotech Hunter | Biotech Hunter